BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38727136)

  • 1. Exploring viral infections' role in Kawasaki disease onset: A study during the COVID-19 pandemic.
    Ishii T; Nawa N; Hosokawa S; Morio T; Fujiwara T
    J Med Virol; 2024 May; 96(5):e29660. PubMed ID: 38727136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.
    Hara T; Furuno K; Yamamura K; Kishimoto J; Mizuno Y; Murata K; Onoyama S; Hatae K; Takemoto M; Ishizaki Y; Kanno S; Sato K; Motomura Y; Sakai Y; Ohga S; Yashiro M; Nakamura Y; Hara T
    JAMA Netw Open; 2021 Apr; 4(4):e214475. PubMed ID: 33822065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
    Iio K; Matsubara K; Miyakoshi C; Ota K; Yamaoka R; Eguchi J; Matsumura O; Okutani T; Ueda I; Nishiyama M
    BMJ Paediatr Open; 2021; 5(1):e001034. PubMed ID: 33884312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan: Results of the 26th Nationwide Survey, 2019 to 2020.
    Ae R; Makino N; Kuwabara M; Matsubara Y; Kosami K; Sasahara T; Nakamura Y
    JAMA Pediatr; 2022 Dec; 176(12):1217-1224. PubMed ID: 36251290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
    Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
    Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
    Ding YY; Ren Y; Qin J; Qian GH; Tang YJ; Chen Y; Li X; Xu L; Qiao CH; Sun L; Lv HT
    World J Pediatr; 2021 Jun; 17(3):263-271. PubMed ID: 34160770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease: A brief history.
    Burns JC; Kushner HI; Bastian JF; Shike H; Shimizu C; Matsubara T; Turner CL
    Pediatrics; 2000 Aug; 106(2):E27. PubMed ID: 10920183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Correlation Between Kawasaki Disease and Infectious Diseases in South Korea.
    Kang JM; Jung J; Kim YE; Huh K; Hong J; Kim DW; Kim MY; Jung SY; Kim JH; Ahn JG
    JAMA Netw Open; 2022 Feb; 5(2):e2147363. PubMed ID: 35129593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus, adeno-associated virus and Kawasaki disease.
    Shike H; Shimizu C; Kanegaye JT; Foley JL; Schnurr DP; Wold LJ; Burns JC
    Pediatr Infect Dis J; 2005 Nov; 24(11):1011-4. PubMed ID: 16282942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence.
    Katsumata N; Harama D; Toda T; Sunaga Y; Yoshizawa M; Kono Y; Hasebe Y; Koizumi K; Hoshiai M; Saito T; Hokibara S; Kobayashi K; Goto M; Sano T; Tsuruta M; Nakamura M; Mizorogi S; Ohta M; Mochizuki M; Sato H; Yokomichi H; Inukai T
    J Epidemiol; 2021 Nov; 31(11):573-580. PubMed ID: 34483151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.
    Kim BJ; Choi A; Kim HS; Oh JH; Lee JY; Kim S; Han JW; Kim K; Kim HH
    J Korean Med Sci; 2022 May; 37(20):e141. PubMed ID: 35607738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory pathogen trends in patients with Kawasaki disease during the COVID-19 pandemic and respiratory syncytial virus epidemic in Japan.
    Namba T; Higuchi Y; Shimizu J
    Pediatr Neonatol; 2023 Sep; 64(5):505-511. PubMed ID: 36878812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel coronavirus infection and Kawasaki disease.
    Bitsadze VO; Grigoreva K; Khizroeva JK; Pervunina TM; Tsibizova VI; Tretyakova MV; Makatsariya AD
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3044-3048. PubMed ID: 32731783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological observations of Kawasaki disease in Japan, 2013-2014.
    Makino N; Nakamura Y; Yashiro M; Sano T; Ae R; Kosami K; Kojo T; Aoyama Y; Kotani K; Yanagawa H
    Pediatr Int; 2018 Jun; 60(6):581-587. PubMed ID: 29498791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States.
    Burney JA; Roberts SC; DeHaan LL; Shimizu C; Bainto EV; Newburger JW; Dominguez S; Jone PN; Jaggi P; Szmuszkovicz JR; Rowley AH; Samuy N; Scalici P; Tremoulet AH; Cayan DR; Burns JC;
    JAMA Netw Open; 2022 Jun; 5(6):e2217436. PubMed ID: 35713905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan.
    Nagao Y; Urabe C; Nakamura H; Hatano N
    Epidemiol Infect; 2016 Feb; 144(3):478-92. PubMed ID: 26201398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature.
    Medaglia AA; Siracusa L; Gioè C; Giordano S; Cascio A; Colomba C
    Ital J Pediatr; 2021 Apr; 47(1):95. PubMed ID: 33874991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.
    Makino N; Nakamura Y; Yashiro M; Kosami K; Matsubara Y; Ae R; Aoyama Y; Yanagawa H
    Pediatr Int; 2019 Apr; 61(4):397-403. PubMed ID: 30786118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative incidence of Kawasaki disease in Japan.
    Nakamura Y; Yashiro M; Yamashita M; Aoyama N; Otaki U; Ozeki Y; Sano T; Kojo T; Ae R; Aoyama Y; Makino N; Kotani K
    Pediatr Int; 2018 Jan; 60(1):19-22. PubMed ID: 29095541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.